Why Reference Measurements Matter Every blood pressure validation study relies on a reliable reference method to evaluate device accuracy. A trusted reference measurement provides the foundation for determining whether a monitoring device delivers accurate and clinically meaningful readings. At Parameters Research Laboratory (PRL), reference measurements are conducted by highly trained clinical research staff with deep experience in physiological monitoring studies. This lev

Blood Pressure Device Validation Studies Accurate blood pressure measurement is fundamental to physiological monitoring. As new technologies expand beyond traditional cuffs into wearable and cuffless blood pressure devices, sponsors must demonstrate performance using a structured blood pressure validation study. These studies evaluate how closely a device’s measurements align with reference measurements obtained through established clinical methods and generate the evidence r

Why Human Factors Matter   Accuracy alone does not determine whether a physiological monitoring device performs well in real-world use. Human factors studies evaluate how users interact with a device during normal operation.  They confirm that the device can be used correctly and repeatedly under the conditions reflected in its claims. For medical device manufacturers, this work strengthens the evidence package by showing that performance is achievable under realistic workflo

Why Multi-Site Studies Matter   Physiological monitoring devices increasingly rely on clinical evidence that reflects real-world use and diverse populations. Some studies may require clinical data to be collected across multiple research locations. Multi-site clinical research studies allow sponsors to expand recruitment and collect larger datasets while maintaining consistent study protocols. When executed under Good Clinical Practice (GCP) and ISO 14155, multi-site program

Why Submission Delays Occur   Regulatory submissions for physiological monitoring devices often depend on clinical evidence demonstrating device performance.  When study protocols are poorly aligned with regulatory expectations, organizations may encounter FDA submission delays .  Common causes include:  incomplete clinical datasets  inconsistent study protocols  inadequate documentation    The Role of Clinical Trial Protocol Development   A well-structured clinical trial pro

Understanding Transfer Standards in Pulse Oximetry Studies   Pulse oximeter development often begins long before a formal accuracy study is performed. During this stage, engineering teams are refining sensors, algorithms, calibration strategies, and signal-quality controls. To move development forward efficiently, they need a reliable way to compare device performance under controlled conditions before initiating a full pulse oximetry study with arterial blood sampling.  This

Well-designed pulse oximetry studies generate regulator-ready datasets for device validation. Regulatory Expectations for Pulse Oximetry Validation   Regulators expect robust clinical evidence when evaluating pulse oximeter performance. This evidence must demonstrate device accuracy across a defined range of oxygen saturation levels.  To generate this evidence, organizations conduct pulse oximetry validation studies in controlled clinical environments. The physiological data

Clinical studies help translate pulse oximeter development into validated physiological performance data. Challenges in Pulse Oximeter Development   Modern pulse oximeters are complex sensing systems that rely on optical measurements and signal processing algorithms. While laboratory testing can evaluate hardware performance, it cannot fully replicate human physiology.  To understand how a device performs during real physiological changes, developers rely on pulse oximetry st

Controlled desaturation protocols allow researchers to evaluate pulse oximeter accuracy across multiple oxygen saturation levels. Why Controlled Desaturation Is Essential for Pulse Oximetry Studies   A pulse oximetry study evaluates how accurately a device estimates arterial oxygen saturation. To measure this performance reliably, researchers must observe device readings across a range of oxygen levels.  This is achieved through a controlled desaturation study , where oxygen

Why Pulse Oximetry Studies Matter for Device Validation   Pulse oximeters play a critical role in physiological monitoring, but demonstrating their accuracy requires carefully designed clinical research studies. Optical sensing systems must be validated against direct measurements of arterial oxygen saturation to confirm their performance across a wide range of oxygen saturations.  A well-designed pulse oximetry study allows researchers to compare device reported oxygen satu

What Is Hypoxia and Why It Matters in Device Validation   Hypoxia refers to a reduction in oxygen availability at the tissue level. In clinical research and pulse oximetry validation, the focus is arterial oxygen saturation (SaO₂) or the percentage of hemoglobin molecules carrying oxygen in the blood.  The Parameters Research Laboratory (PRL) Hypoxia Lab in Broomfield, Colorado is designed for pulse oximetry validation. By safely simulating altitude and lowering oxygen levels

Understanding the Fundamentals Behind Accurate SpO₂ Measurement   Pulse oximetry is deceptively simple on the surface: shine light into tissue, measure what comes back, and estimate oxygen saturation. In practice, pulse oximeter design involves a series of tightly coupled optical, physiological, and signal-processing decisions that directly influence performance, inclusivity, and regulatory readiness.  For device developers, understanding these fundamentals early can reduce d

As wearable and software-enabled technologies increasingly estimate physiological parameters such as oxygen saturation, blood pressure, and heart rate variability, regulatory classification has become a critical design consideration. The FDA’s General Wellness: Policy for Low Risk Devices clarifies when products using non-invasive sensing—such as optical sensing—may be considered general wellness products rather than regulated medical devices.  For developers conducting a cl

Physiological monitoring in wearables has expanded rapidly, but blood pressure and heart-rate sensing now represent two of the most scrutinized technologies for regulators. As devices transition from lifestyle tools to clinical-grade solutions, development teams must demonstrate performance that meets rigorous standards such as ISO 81060-2 , ISO 81060-7, ISO 81060-3 and ISO 14155 .  Parameters Research Laboratory (PRL) supports developers navigating this shift by delivering

Pulse oximetry is broadly adopted across clinical care and wearable technologies. Standardized terminology shared by engineering, clinical research, and regulatory teams promotes aligned protocols, reproducible analyses, and more efficient FDA and CE reviews.   This glossary provides clear definitions of core pulse oximetry terms commonly encountered during pulse oximetry testing, controlled desaturation studies following ISO 80601-2-61 , and regulatory-grade CRO engagements.

A Familiar Framework with Important Regulatory Implications   In January 2026, the FDA released a draft guidance titled “ Cuffless Non-Invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation .” The document outlines FDA’s current recommendations on how cuffless blood pressure (BP) devices—both intermittent and continuous—should be clinically evaluated to support premarket submissions.  For developers already working in this space, the guidance

Dyshemoglobins and Pulse Oximetry: How COHb and MetHb Influence Measurement Accuracy   Pulse oximetry has become central to physiological monitoring across wearables, medical devices, and clinical research studies. Yet even the most advanced sensor architectures face fundamental challenges when hemoglobin exists in altered forms—known as dyshemoglobins . Carboxyhemoglobin (COHb) and methemoglobin (MetHb) change light absorption in ways that directly influence SpO₂ readings an

When planning a clinical research study intended to support an FDA submission , sponsors often encounter terms such as multi-site, multi-investigator , and single-site, multiple-location . While these models may appear operationally similar, they differ in oversight structure, execution, and how evidence is evaluated by the FDA—particularly for cuffless blood pressure devices . Understanding these distinctions is essential for aligning trial design with FDA expectations and w

Accurate oxygen saturation measurement is foundational for modern physiological monitoring, especially for developers of pulse oximeters, wearables, and multiparameter platforms. Yet many devices fail to achieve regulatory expectations because their performance is never tested across the full range of oxygen saturation levels humans experience.  Controlled desaturation studies fill this gap, ensuring claims reflect real-world performance. These studies intentionally and safel

Engineering Reliability: What CTOs Need to Know About Regulatory-Grade Physiological Monitoring Validation   CTOs in medical-device startups face an engineering challenge that extends far beyond hardware and firmware. The success of a physiological monitoring product—whether a pulse oximeter, blood pressure monitor, or wearable sensing platform—depends on rigorous clinical research studies capable of supporting FDA and CE mark submissions. The gap between early engineering va